Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 39: 1590-1597, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersson, A.
Right arrow Articles by Hultberg, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersson, A.
Right arrow Articles by Hultberg, B.

Clinical Chemistry, Vol 39, 1590-1597, Copyright © 1993 by American Association for Clinical Chemistry

Homocysteine and other thiols determined in plasma by HPLC and thiol- specific postcolumn derivatization

A Andersson, A Isaksson, L Brattstrom and B Hultberg
Department of Clinical Chemistry, University Hospital, Lund, Sweden.

We describe a versatile high-performance liquid-chromatographic method for determining homocysteine and other plasma sulfhydryls. Using three different procedures for preparation of plasma, we determined total, free (non-protein-bound), and reduced forms of homocysteine, cysteine, glutathione, cysteinylglycine, and gamma-glutamylcysteine in human plasma. Sample preparation involves disulfide reduction with dithiothreitol and protein precipitation with sulfosalicylic acid. The assay utilizes isocratic reversed-phase ion-pair liquid chromatography at pH 2.4, postcolumn derivatization with 4,4'-dithiodipyridine, and colorimetric detection at 324 nm. The intra-assay precision (CV) of the method for total homocysteine is 1.5%; the interassay precision over 2.5 months is 2.5%. The detection limit for homocysteine is < 50 nmol/L plasma.


The following articles in journals at HighWire Press have cited this article:


Home page
 British Journal of Diabetes & Vascular DiseaseHome page
C. Livingstone and J. Davis
Review: Targeting therapeutics against glutathione depletion in diabetes and its complications
The British Journal of Diabetes & Vascular Disease, November 1, 2007; 7(6): 258 - 265.
[Abstract] [PDF]

Home page
 ANGIOLOGYHome page
P. Lind, B. Hedblad, B. Hultberg, L. Stavenow, L. Janzon, and F. Lindgarde
Risk of Myocardial Infarction in Relation to Plasma Levels of Homocysteine and Inflammation-Sensitive Proteins: A Long-Term Nested Case-Control Study
Angiology, July 1, 2003; 54(4): 401 - 410.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
R. H. Williams, J. A. Maggiore, R. D. Reynolds, and C. M. Helgason
Novel Approach for the Determination of the Redox Status of Homocysteine and Other Aminothiols in Plasma from Healthy Subjects and Patients with Ischemic Stroke
Clin. Chem., June 1, 2001; 47(6): 1031 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Arnadottir, B. Hultberg, and A.-L. Berg
Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephrophathy
Nephrol. Dial. Transplant., January 1, 2001; 16(1): 45 - 47.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
K. Nilsson, L. Gustafson, and B. Hultberg
The Plasma Homocysteine Concentration Is Better Than That of Serum Methylmalonic Acid as a Marker for Sociopsychological Performance in a Psychogeriatric Population
Clin. Chem., May 1, 2000; 46(5): 691 - 696.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Arnadottir, V. Gudnason, and B. Hultberg
Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations
Nephrol. Dial. Transplant., April 1, 2000; 15(4): 524 - 528.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Andersson, A. Lindgren, M. Arnadottir, H. Prytz, and B. Hultberg
Thiols as a Measure of Plasma Redox Status in Healthy Subjects and in Patients with Renal or Liver Failure
Clin. Chem., July 1, 1999; 45(7): 1084 - 1087.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. C. Martin, I. Tsakas-Ampatzis, W. A. Bartlett, and A. F. Jones
Measurement of Plasma Total Homocysteine by HPLC with Coulometric Detection
Clin. Chem., January 1, 1999; 45(1): 150 - 152.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. W. Jacobsen
Homocysteine and vitamins in cardiovascular disease
Clin. Chem., August 1, 1998; 44(8): 1833 - 1843.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Pastore, R. Massoud, C. Motti, A. L. Russo, G. Fucci, C. Cortese, and G. Federici
Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine
Clin. Chem., April 1, 1998; 44(4): 825 - 832.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. Lindgren, L. Brattstrom, B. Norrving, B. Hultberg, A. Andersson, and B. B. Johansson
Plasma Homocysteine in the Acute and Convalescent Phases After Stroke
Stroke, May 1, 1995; 26(5): 795 - 800.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.